World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
31107
World Ranking
1109
National Ranking
8

Medicine

D-Index
89
Citations
31183
World Ranking
12631
National Ranking
142

Overview

Olli Vapalahti is affiliated with the University of Helsinki in Finland, specializing primarily in the field of Medicine. Their research portfolio encompasses various subfields, including Infectious Diseases, Public Health, Environmental and Occupational Health, Molecular Biology, Epidemiology, and Neurology.

The scientist's work focuses extensively on topics related to viral infections and outbreak research with an emphasis on SARS-CoV-2 and COVID-19. Other main topics include COVID-19 clinical research studies, long-term effects of COVID-19, viral infections and vectors, mosquito-borne diseases and control, as well as SARS-CoV-2 detection and testing.

Vapalahti's recent publications illustrate a focus on COVID-19 and related infectious diseases. Notable papers include:

  • "Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity" (2020), published in Science
  • "A serological assay to detect SARS-CoV-2 seroconversion in humans" (2020), published in Nature Medicine
  • "A serological assay to detect SARS-CoV-2 seroconversion in humans" (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • "COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants" (2021), published in Nature Communications
  • "Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020" (2020), published in Eurosurveillance

Frequent co-authors in their research include Tarja Sironen, Teemu Smura, Ravi Kant, Jussi Hepojoki, and Tomas Strandin. These collaborations suggest a network of researchers active in infectious diseases and related fields.

Vapalahti has contributed to multiple publications appearing in prominent scientific venues. The most frequent venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Viruses
  • Emerging Infectious Diseases
  • Research Square (Research Square)
  • Eurosurveillance

Their work in infectious diseases is extensive, with a significant portion dedicated specifically to SARS-CoV-2 research and its clinical implications. This body of work situates Vapalahti among active researchers addressing viral pathogenesis, immune responses, and epidemiological dynamics related to emerging infectious diseases.

Best Publications

  • A serological assay to detect SARS-CoV-2 seroconversion in humans.

    Fatima Amanat;Daniel Stadlbauer;Shirin Strohmeier;Shirin Strohmeier;Thi H. O. Nguyen

  • Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.

    Ludovico Cantuti-Castelvetri;Ludovico Cantuti-Castelvetri;Ravi Ojha;Liliana D. Pedro;Liliana D. Pedro;Minou Djannatian;Minou Djannatian

  • A Global Perspective on Hantavirus Ecology, Epidemiology, and Disease

    Colleen B. Jonsson;Luiz Tadeu Moraes Figueiredo;Olli Vapalahti

  • Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.

    Rita W. Driggers;Cheng-Ying Ho;Essi M. Korhonen;Suvi Kuivanen

  • Tick-borne encephalitis

    Lars Lindquist;Olli Vapalahti

  • Hantavirus infections in Europe.

    Olli Vapalahti;Jukka Mustonen;Åke Lundkvist;Heikki Henttonen

  • Hantaviruses: genome structure, expression and evolution.

    Alexander Plyusnin;Olli Vapalahti;Antti Vaheri

  • Hantavirus infections in Europe and their impact on public health.

    Antti Vaheri;Antti Vaheri;Heikki Henttonen;Liina Voutilainen;Liina Voutilainen;Jukka Mustonen

  • Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment

    Eva R. Kallio;Eva R. Kallio;Eva R. Kallio;Jonas Klingström;Jonas Klingström;Elisabeth Gustafsson;Tytti Manni

  • Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue.

    Päivi Norja;Kati Hokynar;Leena-Maija Aaltonen;Renwei Chen

  • Recent Zika Virus Isolates Induce Premature Differentiation of Neural Progenitors in Human Brain Organoids

    Elke Gabriel;Anand Ramani;Ulrike Karow;Marco Gottardo

  • Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020.

    Anu Haveri;Teemu Smura;Suvi Kuivanen;Pamela Österlund

  • COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants.

    Pinja Jalkanen;Pekka Kolehmainen;Hanni K. Häkkinen;Moona Huttunen

  • Tula virus: a newly detected hantavirus carried by European common voles.

    A Plyusnin;O Vapalahti;H Lankinen;H Lehväslaiho

  • Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus

    Jukka Mustonen;Jukka Mustonen;Jukka Mustonen;Jukka Partanen;Jukka Partanen;Jukka Partanen;Mari Kanerva;Mari Kanerva;Mari Kanerva;Kari Pietilä;Kari Pietilä;Kari Pietilä

  • Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.

    Erik Alm;Eeva K Broberg;Thomas Connor;Emma B Hodcroft

  • Human B‐cell epitopes of puumala virus nucleocapsid protein, the major antigen in early serological response

    Olli Vapalahti;Hannimari Kallio‐Kokko;Ale Närvänen;Ilkka Julkunen

  • Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018

    Piet Maes;Sergey V. Alkhovsky;Yīmíng Bào;Martin Beer

  • Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.

    Lucie Rodriguez;Pirkka Pekkarinen;Tadepally Lakshmikanth;Ziyang Tan

  • Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein.

    Olli Vapalahti;Hannimari Kallio-Kokko;Eeva-Marjatta Salonen;Markus Brummer-Korvenkontio

  • Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.

    AJ Jääskeläinen;S Kuivanen;E Kekäläinen;MJ Ahava

  • Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter.

    Kirsi M. Jääskeläinen;Pasi Kaukinen;Ekaterina S. Minskaya;Angelina Plyusnina

  • Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia.

    K Nemirov;O Vapalahti;A Lundkvist;V Vasilenko

  • Hantavirus infections in Europe

    Alexander Plyusnin;Detlev H Krüger;Åke Lundkvist

Frequent Co-Authors

Antti Vaheri
Antti Vaheri University of Helsinki
Heikki Henttonen
Heikki Henttonen Natural Resources Institute Finland
Alexander Plyusnin
Alexander Plyusnin University of Helsinki
Anja Kipar
Anja Kipar University of Zurich
Ake Lundkvist
Ake Lundkvist Uppsala University
Ake Lundkvist
Ake Lundkvist Uppsala University
Ilkka Julkunen
Ilkka Julkunen University of Turku
Klaus Hedman
Klaus Hedman University of Helsinki
Juha Laakkonen
Juha Laakkonen University of Helsinki
Maija Lappalainen
Maija Lappalainen University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related online degrees in nursing can open diverse career opportunities. Many professionals begin with an online BSN programs for non nurses, which provide a solid foundation in healthcare and prepare students for advanced roles.

Accelerated options are available as well, allowing faster progression through rigorous coursework. The accelerated nurse practitioner programs are designed to help students quickly gain the practical skills needed to excel in clinical environments, often combining theoretical and hands-on training effectively.

Specializing further, registered nurses may pursue acute care nurse practitioner certification which focuses on providing care for critically ill patients. This transition enhances career prospects and allows for work in fast-paced, high-stakes medical settings.

Additionally, understanding earning potential is critical. According to how much do dnps make, salaries for Doctor of Nursing Practice (DNP) professionals vary by region but remain competitive, reflecting the advanced skills and expertise they bring to immunology and healthcare fields.

Best Scientists Citing Olli Vapalahti

Trending Scientists

Recently Published Articles